A new system for advanced drug screening using microimaging technology
Four-dimensional multi-modality microimaging-microdevice system for high throughput drug screening in vivo
This study is working on a new technology that helps test how well different drugs work in living organisms, which could lead to more personalized and effective treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10915495 on NIH RePORTER |
What this research studies
This research focuses on developing a cutting-edge microimaging and microdevice system that allows for high-throughput drug screening in living organisms. By combining advanced optical imaging techniques with innovative microdevices, the project aims to enhance the drug development process and improve personalized healthcare. Patients may benefit from this technology as it could lead to more effective and tailored treatments based on individual responses to drugs. The research involves in vivo testing, which means it will be conducted in living subjects to assess how drugs interact with tissues.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are undergoing treatment for conditions that require new drug therapies or personalized medicine approaches.
Not a fit: Patients who are not seeking new treatment options or those with conditions that are not addressed by the drugs being screened may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the efficiency and effectiveness of drug development, leading to better treatment options for patients.
How similar studies have performed: Other research has shown promise with similar microimaging techniques, indicating that this approach could lead to significant advancements in drug screening.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Liu, Guigen — Brigham and Women's Hospital
- Study coordinator: Liu, Guigen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.